The Effect of Supplementation With Species of Lactobacillus on Anthropometric Measurements
1 other identifier
interventional
72
1 country
1
Brief Summary
The investigators aimed to study the effect of supplementation with species of Lactobacillus on anthropometric measurements, body composition, appetite and serum lipid profile in overweight and obese adults
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 6, 2015
CompletedFirst Posted
Study publicly available on registry
May 20, 2015
CompletedMay 20, 2015
June 1, 2014
11 months
May 6, 2015
May 16, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
weight change
Change from Baseline in body weight at 12 weeks
Secondary Outcomes (11)
defecation
Baseline,4 weeks, 8 weeks, 12 weeks
blood pressure
Baseline,12 weeks
Anthropometric Measurement BMI
Baseline,4 weeks, 8 weeks, 12 weeks
Anthropometric Measurement WC
Baseline,12 weeks
Anthropometric Measurement HC
Baseline,12 weeks
- +6 more secondary outcomes
Study Arms (2)
Species of Lactobacillus
EXPERIMENTAL2 capsule/day of Lactofem Containing Species of Lactobacillus
lactose
PLACEBO COMPARATOR2 capsule/day Containing lactose
Interventions
2 capsule a day Lactofem probiotics containing Species of Lactobacillus
Eligibility Criteria
You may qualify if:
- Age 18-65 years
- BMI more than 25 Kg/m2
You may not qualify if:
- taking drugs that could affect weight change, including anti-diabetic drugs, lipid lowering drugs
- endocrine,cardiovascular, thyroid, or chronic liver disease.
- had received surgery to reduce weight
- taking probiotics or antibiotics within one month
- Pregnancy or lactation or menopause
- A history of cancer
- Heart disease - cardiovascular, pulmonary, renal and diabetes
- A history of autoimmune disease
- Taking certain medications such as blood pressure control, statins, insulin sensitivity enhancers
- weight change over five percent within three months
- change in activity or diet habit
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
sardrood Clinic
Tabriz, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammad Alizadeh, PhD
Department of Nutrition, School of Medicine, Urmia University of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2015
First Posted
May 20, 2015
Study Start
February 1, 2014
Primary Completion
January 1, 2015
Study Completion
February 1, 2015
Last Updated
May 20, 2015
Record last verified: 2014-06